Please assess the completion status of the following clinical trial:

Trial Title: Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* A current clinical diagnosis of Chronic Obstructive Pulmonary Disease~* Documented Chronic Obstructive Pulmonary Disease symptoms for more than 2 years~* A smoking history of at least 10 pack years~Exclusion Criteria:~* History and/or current clinical diagnosis of asthma~* History and/or current clinical diagnosis of atopic diseases such as allergic rhinitis

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Symbicort Turbuhaler 160/4.5 microgram, 2 inhalations twice daily
- 2 (Type: ACTIVE_COMPARATOR): Oxis Turbuhaler 4.5 microgram, 2 inhalations twice daily

Based on this trial design, predict the completion outcome and termination type (if applicable).